SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-180306
Filing Date
2019-06-25
Accepted
2019-06-24 17:37:34
Documents
6
Period of Report
2019-06-24

Document Format Files

Seq Description Document Type Size
1 6-K d762730d6k.htm 6-K 9513
2 EX-99.1 d762730dex991.htm EX-99.1 15036
3 EX-99.2 d762730dex992.htm EX-99.2 18007
4 GRAPHIC g762730g0619210959893.jpg GRAPHIC 2906
5 GRAPHIC g762730g15q65.jpg GRAPHIC 4942
6 GRAPHIC g762730pik1.jpg GRAPHIC 15945
  Complete submission text file 0001193125-19-180306.txt   76919
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38281 | Film No.: 19916303
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences